Cohort 1 (Group A) - Ferric Carboxymaltose (FCM) [clinicaltrials_resource:NCT00982007/group/P1]
Intravenous (IV) iron
Ferric Carboxymaltose (FCM) : A total maximum cumulative dose of 1500 mg administered on Days 0 and 7.
participant counts in P1 for milestone 2 of NCT00982007 [clinicaltrials_resource:NCT00982007/milestone/1/p/1]participant counts in P1 for milestone 3 of NCT00982007 [clinicaltrials_resource:NCT00982007/milestone/2/p/1]participant counts in P1 for milestone 4 of NCT00982007 [clinicaltrials_resource:NCT00982007/milestone/3/p/1]participant flow for clinicaltrials:NCT00982007 [clinicaltrials_resource:deed1bcadfa96cdf64c55270397070d8]
group [clinicaltrials_vocabulary:group]
Cohort 1 (Group A) - Ferric Carboxymaltose (FCM) [clinicaltrials_resource:NCT00982007/group/P1]
Intravenous (IV) iron
Ferric Carboxymaltose (FCM) : A total maximum cumulative dose of 1500 mg administered on Days 0 and 7.
Bio2RDF identifier
NCT00982007/group/P1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT00982007/group/P1
group id [clinicaltrials_vocabulary:group-id]
description
Intravenous (IV) iron
Ferric C ...... administered on Days 0 and 7.
@en
identifier
clinicaltrials_resource:NCT00982007/group/P1
title
Cohort 1 (Group A) - Ferric Carboxymaltose (FCM)
@en
type
label
Cohort 1 (Group A) - Ferric Ca ...... resource:NCT00982007/group/P1]
@en